UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improved detection of sinusoidal obstructive syndrome using pediatric–AYA diagnostic criteria and severity grading

Bone marrow transplantation (Basingstoke), 2021-01, Vol.56 (1), p.175-184

2021

Volltextzugriff (PDF)

Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes

Bone marrow transplantation (Basingstoke), 2017-01, Vol.52 (1), p.20-27

2017

Volltextzugriff (PDF)

Long-term outcomes of Sleeping Beauty–generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas

Blood, 2020-03, Vol.135 (11), p.862-865

2020

Volltextzugriff (PDF)

Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation

Leukemia, 2013-04, Vol.27 (4), p.836-842

2013

Volltextzugriff (PDF)

Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients

Bone marrow transplantation (Basingstoke), 2017-04, Vol.52 (4), p.580-587

2017

Volltextzugriff (PDF)

Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors

Haematologica (Roma), 2014-02, Vol.99 (2), p.322-328

2014

Volltextzugriff (PDF)

Umbilical cord blood graft engineering: challenges and opportunities

Bone marrow transplantation (Basingstoke), 2015-06, Vol.50 (Suppl 2), p.S55-S62

2015

Volltextzugriff (PDF)

Disseminated cryptococcal infection in allogeneic stem cell transplant patients: a rare cause of acute kidney injury

Bone marrow transplantation (Basingstoke), 2016-10, Vol.51 (10), p.1301-1304

2016

Volltextzugriff (PDF)

Leukemia cell mobilization with G-CSF plus plerixafor during busulfan–fludarabine conditioning for allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2015-07, Vol.50 (7), p.939-946

2015

Volltextzugriff (PDF)

Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts

Bone marrow transplantation (Basingstoke), 2015-04, Vol.50 (4), p.493-498

2015

Volltextzugriff (PDF)

Graft-Versus-Host Disease Following Radiation Therapy in Patients With a History of Allogeneic Stem Cell Transplant

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E457-E457

2015

Volltextzugriff (PDF)

Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors

Leukemia, 2017-07, Vol.31 (7), p.1654-1657

2017

Volltextzugriff (PDF)

Proton Versus Photon Craniospinal Irradiation for Hematologic Malignancies Involving the CNS: Effectiveness and Toxicity in the Setting of Stem Cell Transplant

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E496-E496

2016

Volltextzugriff (PDF)

OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN AND PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION

Hematology, Transfusion and Cell Therapy, 2023-10, Vol.45, p.S256-S257

2023

Volltextzugriff (PDF)

Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma

Leukemia, 2015-09, Vol.29 (9), p.1945-1948

2015

Volltextzugriff (PDF)

Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia

Bone marrow transplantation (Basingstoke), 2013-05, Vol.48 (5), p.666-670

2013

Volltextzugriff (PDF)

Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice

Transplant infectious disease, 2014-12, Vol.16 (6), p.878-886

2014

Volltextzugriff (PDF)

Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome

Bone marrow transplantation (Basingstoke), 2009-06, Vol.43 (11), p.839-843

2009

Volltextzugriff (PDF)

Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation

Bone marrow transplantation (Basingstoke), 2016-07, Vol.51 (7), p.999-1001

2016

Volltextzugriff (PDF)

P367: LONG TERM OUTCOMES OF NEWLY DIAGNOSED CRLF2 REARRANGED B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA

HemaSphere, 2022-06, Vol.6, p.267-268

2022

Volltextzugriff (PDF)

P372: DISMAL OUTCOMES OF PATIENTS WITH RELAPSED/REFRACTORY B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA AFTER FAILURE OF BOTH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB

HemaSphere, 2022-06, Vol.6, p.272-273

2022

Volltextzugriff (PDF)

P1376: LENALIDOMIDE–BASED MAINTENANCE AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT FOR PATIENTS WITH HIGH RISK MULTIPLE MYELOMA

HemaSphere, 2022-06, Vol.6 (Suppl), p.1260-1261

2022

Volltextzugriff (PDF)

P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T‐ACUTE LYMPHOBLASTIC LEUKEMIA/T‐LYMPHOBLASTIC LYMPHOMA (T‐ALL/LBL)

HemaSphere, 2022-06, Vol.6, p.265-266

2022

Volltextzugriff (PDF)

CLINICAL IMPLICATIONS OF CYTOPENIAS BEYOND DAY 30 AFTER AXI‐CEL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA

Hematological oncology, 2019-06, Vol.37 (S2), p.311-312

2019

Volltextzugriff (PDF)

Alopecia areata after HLA-identical BMT from an affected, sibling donor

Bone marrow transplantation (Basingstoke), 2014-04, Vol.49 (4), p.592-594

2014

Volltextzugriff (PDF)

1 – 25 von 192

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(126)
Mit Volltextzugriff
(181)

Publikationsform

Sprache

Englisch
(192)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(76)
Science & Technology
(76)
Hematology
(67)
Humans
(64)
Hematology, Oncology And Palliative Medicine
(56)
Transplantation
(47)
Male
(39)
Immunology
(38)
Female
(36)
Oncology
(36)
Middle Aged
(34)
Adult
(33)
Stem Cell Transplantation
(30)
Stem Cells
(28)
Internal Medicine
(27)
Medicine
(27)
Medicine & Public Health
(27)
Medicine/public Health
(26)
Biophysics
(23)
Aged
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Biology Of Blood And Marrow Transplantation
(62)
Blood
(30)
Bone Marrow Transplantation
(24)
Hemasphere
(8)
Blood Advances
(7)
Leukemia
(7)
Transplantation And Cellular Therapy
(7)
Journal Of Clinical Oncology
(6)
Haematologica
(4)
Annals Of Oncology
(3)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Improved detection of sinusoidal obstructive syndrome using pediatric–AYA diagnostic criteria and severity grading

Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes

Long-term outcomes of Sleeping Beauty–generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas

Prognostic significance of 11q23 aberrations in adult acute myeloid leukemia and the role of allogeneic stem cell transplantation

Fludarabine with pharmacokinetically guided IV busulfan is superior to fixed-dose delivery in pretransplant conditioning of AML/MDS patients

Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors

Umbilical cord blood graft engineering: challenges and opportunities

Disseminated cryptococcal infection in allogeneic stem cell transplant patients: a rare cause of acute kidney injury

Leukemia cell mobilization with G-CSF plus plerixafor during busulfan–fludarabine conditioning for allogeneic stem cell transplantation

Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts

Graft-Versus-Host Disease Following Radiation Therapy in Patients With a History of Allogeneic Stem Cell Transplant

Donor type, in addition to transplantation in chronic phase and myeloablative conditioning, influence transplant survival for patients with advanced chronic myeloid leukemia in the era of tyrosine kinase inhibitors

Proton Versus Photon Craniospinal Irradiation for Hematologic Malignancies Involving the CNS: Effectiveness and Toxicity in the Setting of Stem Cell Transplant

OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN AND PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION

Phase I/II trial of lenalidomide and high-dose melphalan with autologous stem cell transplantation for relapsed myeloma

Outcomes of second allogeneic hematopoietic stem cell transplantation for patients with acute lymphoblastic leukemia

Vaccination guidelines after hematopoietic stem cell transplantation: practitioners' knowledge, attitudes, and gap between guidelines and clinical practice

Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome

Outcomes in hepatitis C virus seropositive lymphoma and myeloma patients after autologous stem cell transplantation

P367: LONG TERM OUTCOMES OF NEWLY DIAGNOSED CRLF2 REARRANGED B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA

P372: DISMAL OUTCOMES OF PATIENTS WITH RELAPSED/REFRACTORY B‐CELL ACUTE LYMPHOBLASTIC LEUKEMIA AFTER FAILURE OF BOTH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB

P1376: LENALIDOMIDE–BASED MAINTENANCE AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT FOR PATIENTS WITH HIGH RISK MULTIPLE MYELOMA

P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T‐ACUTE LYMPHOBLASTIC LEUKEMIA/T‐LYMPHOBLASTIC LYMPHOMA (T‐ALL/LBL)

CLINICAL IMPLICATIONS OF CYTOPENIAS BEYOND DAY 30 AFTER AXI‐CEL THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA

Alopecia areata after HLA-identical BMT from an affected, sibling donor

Suchergebnisse filtern